Farmers & Merchants Trust Co of Chambersburg PA’s BioCryst Pharmaceuticals BCRX Stock Holding History

Farmers & Merchants Trust Co of Chambersburg PA’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5K	Hold	500	–	–	﹤0.01%	309
2026 Q1	$5K	Hold	500	–	–	﹤0.01%	293
2025 Q4	$4K	Hold	500	–	–	﹤0.01%	305
2025 Q3	$4K	Hold	500	–	–	﹤0.01%	310
2025 Q2	$4K	Hold	500	–	–	﹤0.01%	318
2025 Q1	$4K	Hold	500	–	–	﹤0.01%	351
2024 Q4	$4K	Hold	500	–	–	﹤0.01%	342
2024 Q3	$4K	Hold	500	–	–	﹤0.01%	330
2024 Q2	$3K	Hold	500	–	–	﹤0.01%	352
2024 Q1	$3K	Hold	500	–	–	﹤0.01%	372
2023 Q4	$3K	Hold	500	–	–	﹤0.01%	391
2023 Q3	$4K	Hold	500	–	–	﹤0.01%	331
2023 Q2	$4K	Hold	500	–	–	﹤0.01%	345
2023 Q1	$4K	Hold	500	–	–	﹤0.01%	319
2022 Q4	$6K	Hold	500	–	–	﹤0.01%	294
2022 Q3	$6K	Hold	500	–	–	﹤0.01%	269
2022 Q2	$5K	Hold	500	–	–	﹤0.01%	305
2022 Q1	$8K	Hold	500	–	–	0.01%	262
2021 Q4	$7K	Hold	500	–	–	﹤0.01%	286
2021 Q3	$7K	Hold	500	–	–	0.01%	271
2021 Q2	$8K	Hold	500	–	–	0.01%	283
2021 Q1	$5K	Hold	500	–	–	﹤0.01%	263
2020 Q4	$4K	Hold	500	–	–	﹤0.01%	254
2020 Q3	$2K	Hold	500	–	–	﹤0.01%	259
2020 Q2	$2K	Hold	500	–	–	﹤0.01%	276
2020 Q1	$1K	Hold	500	–	–	﹤0.01%	277
2019 Q4	$2K	Hold	500	–	–	﹤0.01%	297
2019 Q3	$1K	Hold	500	–	–	﹤0.01%	317
2019 Q2	$2K	Hold	500	–	–	﹤0.01%	290
2019 Q1	$4K	Hold	500	–	–	﹤0.01%	283
2018 Q4	$4K	Hold	500	–	–	﹤0.01%	247
2018 Q3	$4K	Hold	500	–	–	﹤0.01%	256
2018 Q2	$3K	Hold	500	–	–	﹤0.01%	257
2018 Q1	$2.38K	Hold	500	–	–	﹤0.01%	261
2017 Q4	$2.46K	Hold	500	–	–	﹤0.01%	266
2017 Q3	$2.62K	Hold	500	–	–	﹤0.01%	265
2017 Q2	$2.78K	Hold	500	–	–	﹤0.01%	274
2017 Q1	$4.2K	Hold	500	–	–	﹤0.01%	269
2016 Q4	$3.17K	Buy	+500	New	+$2.6K	﹤0.01%	272

Other funds holding BCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Farmers & Merchants Trust Co of Chambersburg PA's BCRX Position: Q2 2026 in Review

Farmers & Merchants Trust Co of Chambersburg PA held its BioCryst Pharmaceuticals (BCRX) position steady in Q2 2026 at 500 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #309.

Farmers & Merchants Trust Co of Chambersburg PA first reported a position in BCRX in Q4 2016 and has held it in 39 quarters since. The position peaked at $8K in Q1 2022. 195 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.

Farmers & Merchants Trust Co of Chambersburg PA held 500 shares of BioCryst Pharmaceuticals worth $5K as of Q2 2026.
Farmers & Merchants Trust Co of Chambersburg PA left its BioCryst Pharmaceuticals share count unchanged in Q2 2026.
BioCryst Pharmaceuticals made up ﹤0.01% of Farmers & Merchants Trust Co of Chambersburg PA's portfolio in Q2 2026, its #309 holding.
Farmers & Merchants Trust Co of Chambersburg PA first reported a position in BioCryst Pharmaceuticals in Q4 2016 and has held it in 39 quarters since.
Farmers & Merchants Trust Co of Chambersburg PA's BioCryst Pharmaceuticals position peaked at $8K in Q1 2022.
195 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.

Based on Farmers & Merchants Trust Co of Chambersburg PA's 13F filing for Q2 2026, filed 24 Jul 2026.